Skip to main content
Clinical Trials/NCT06662682
NCT06662682CompletedNot Applicable

Acute Effects of Whole-Body Vibration on Pain, Neuromuscular Performance and Gait Quality in Patients with Knee Osteoarthritis. a Randomized Controlled Trial.

University of Erlangen-Nürnberg Medical School1 site in 1 country20 target enrollmentStarted: July 15, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Changes in pain of the osteo-arthrotic knee

Study Overview

Brief Summary

Knee osteoarthritis is a chronic joint disease with an impact on quality of life and an increasing incidence what leads to huge costs and burden on the economy.

The present study investigates immediate effects of whole-body vibration on pain, neuromuscular performance, and gait quality in patients with knee osteoarthritis. Eligible patients (n=20) with knee osteoarthritis grade 2 or 3 on Kallgren Lawrence will complete a 5 minute WBV training and a control condition in a randomized order (cross over design). Pain, maximum strength of the leg flexors and extensors, the chair rise test and gait parameters will be measured directly before and after the intervention/control.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Outcome assessor were unaware of participants status and were not allowed to ask correpondingly

Eligibility Criteria

Ages
40 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •x-ray confirmed knee osteoarthritis (Kallgren-Lawrence 2-3)
  • •knee pain (NRS 0-10 >2) for 3 months and at least 50% of the last 30 days

Exclusion Criteria

  • •contraindications for WBV (acute injuries of the musculoskeletal system, new joint endoprosthesis, pregnancy, acute thrombosis, Epilepsia, cholecystolithiasis, nephrolithiasis, heart pace maker),
  • •other pathologies affecting gait or neuromuscular performance (rheumatic
  • •opioid medications, cortisol medications and intraarticular injections in the knee during the ist 3 months.

Arms & Interventions

Whole-Body Vibration

Experimental

The intervention (IC) will be specified as a five-minute Whole-Body Vibration session.

Intervention: Whole-Body Vibration (Other)

Control Condition

Other

The control condition (CC) will conduct the same protocol as the intervention condition. The only difference will be that the vibration plate will be switched off.

Intervention: Control Condition (Other)

Outcomes

Primary Outcomes

Changes in pain of the osteo-arthrotic knee

Time Frame: Changes in pain of the osteoarthrotic knee during the treadmill test as determined on a visual analogue scale (VAS 0-10) before and after 5 min of intervention

Changes in pain of the osteo-arthrotic knee during the treadmill test as determined on a visual analogue scale (VAS 0-10).

Secondary Outcomes

  • Changes in isometric maximum leg flexion strength of the osteoarthritis knee(Changes in isometric maximum leg flexion strength of the osteoarthritis knee before and after 5 min of Intervention.)
  • Changes in isometric maximum leg extension strength of the osteoarthritis knee(Changes in isometric maximum leg extension strength of the osteoarthritis knee before and after 5 min of Intervention)
  • Changes of number of repetitions in the 30 s sit to stand (chair rise) test(Changes in number of repetitions in the 30 s sit-to-stand test before and after 5 min of intervention)
  • Changes of ipsilateral stride length(Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab ( (Firma Diers Formetric, Germany) before and after 5 min of Intervention)
  • Changes of ipsilateral stride time(Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention.)
  • Changes of stride width(Changes of stride width (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention.)
  • Changes of ipsilateral stance time(Changes of ipsilateral stance time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention)
  • Changes of ipsilateral single support time(Changes of ipsilateral single support time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention)
  • Changes of double support time(Changes of double support time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention)
  • Changes of trunk inclination(Changes of trunk inclination (mm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention)
  • Changes of ipsilateral und kontralateral knee angle in frontal plane(Changes of ipsilateral und kontralateral knee angle (°) in frontal plane at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention)
  • Changes of ipsilateral und kontralateral knee angle in sagital plane(Changes of ipsilateral und kontralateral knee angle in sagital plane (°) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention)

Investigators

Sponsor
University of Erlangen-Nürnberg Medical School
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Wolfgang Kemmler, PhD

Head of Research

Friedrich-Alexander-Universität Erlangen-Nürnberg

Study Sites (1)

Loading locations...

Similar Trials